Dental treatment of a Seven-Year-Old Child with Mastocytosis

Aim: Mastocytosis is a rare disorder characterized by pathologic mast cell degranulation. This paper aims to present the dental management of a seven-year-old girl diagnosed with mastocytosis, in a hospital setting, yet without general anesthesia. Case Report: A seven-year-old girl, diagnosed with urticaria pigmentosa, was referred to a dental practice. Her parents’ main concern was a possible allergic reaction to local anesthetics and antibiotics. It was decided to perform treatment in the operating theatre of a clinic without general anesthesia. Eight primary teeth were restored. The patient was monitored, and no complications occurred throughout the procedure. Follow-ups performed every three months for two years after treatment. Patient’s oral hygiene was improved significantly. Conclusion: Collaboration between medical experts, patient’s family and the pediatric dentist was crucial. The dentist must be aware of the medical history and potential triggering factors. Due to high probability for life-threatening emergencies, dental treatment in a hospital setting is recommended.

Mastocytosis; Urticaria pigmentosa; Pediatric dental treatment

1. Longley J, Duffy TP, Kohn S. The mast cell and mast cell disease. J Am Acad Dermatol, 1988; 32:545-561.

2. Castells M, Metcalfe DD, Escribano L. Diagnosis and treatment of cutaneous mastocytosis in children-Practical Recommendations. Am J Clin Dermatol, 2011; 12(4):259-270.

3. Sangster A. An anomalous mottled rash, accompanied by pruritus, factitious and pigmentation, ‘urticaria pigmentosa’. Trans Clin Soc Lond, 1878; 11:161-163.

4. Brockow K. Epidemiology, Prognosis, and Risk Factors in Mastocytosis. Immunol Allergy Clin N Am, 2014; 34:283-295.

5. Soter NA. The skin in mastocytosis. J Invest Dermatol, 1991; 96(3):32S-38S.

6. Uzzaman A, Maric I, Noel P, et al. Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology. Pediatr Blood Cancer, 2009; 53(4):629–634.

7. Pauls JD, Brems J, Pockros PJ, Saven A, Wagner RL, Weber R, et al. Mastocytosis diverse presentations and outcomes. Arch Intern Med, 1999; 159:401-405.

8. American Academy of Pediatric Dentistry (AAPD). Management of medical emergencies. The Reference Manual of Pediatric Dentistry. Ed. American Academy of Pediatric Dentistry, Chicago, 2020; 600-601.

9. Suri L, Gagari E, Vastardis E. Delayed tooth eruption: Pathogenesis, diagnosis, and treatment. A literature review. Am J Orthod Dentofacial Orthop, 2004; 126(4):432-445.

10. Klingberg G. Dental anxiety and behaviour management problems in paediatric dentistry: a review of background factors and diagnostics. Eur Arch Paediatr Dent, 2007; 8(4):11–15.

11. American Academy of Pediatric Dentistry (AAPD). Behavior guidance for the pediatric dental patient. The Reference Manual of Pediatric Dentistry. Ed. American Academy of Pediatric Dentistry, Chicago, 2020; 292-310.

12. Rama TA, Corte-Real I, Gomes PS, Escribano L, Fernandes MH. Mastocytosis: oral implications of a rare disease. J Oral Pathol Med, 2011; 40:441-450.

13. Heide R, van Doorn K, Mulder PG, et al. Serum tryptase and SCORMA (SCORingMAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis. Clin Exp Dermatol, 2009; 34(4):462-468.

14. Carter MC, Uzzaman A, Scott LM, Metcalfe DD, Quezado Z. Pediatric Mastocytosis: Routine anesthetic management for a complex disease. Anesth Analg, 2008; 107(2):422-427.

15. Nelson LP, Savelli-Castillo I. Dental management of a pediatric patient with mastocytosis: a case report. Pediatr Dent, 2002; 24:343–346.

16. Munksgaard EC. Toxicology versus allergy in restorative dentistry. Adv Dent Res, 1992; 6:17-21.

17. Ring J, Franz R, Brockow K. Anaphylactic reactions to local anesthetics. Chem Immunol Allergy, 2010; 95:190–200.

18. Coleman MA, Liberthson RR, Crone RK, Levine FH. General anesthesia in a child with urticaria pigmentosa. Anesth Analg, 1980; 59(9):704-706.

19. Davidovich E, Ronin L, Ram D. Mastocytosis-oral and dental manifestations and medical considerations for dental treatment: a case report. J Disabil Oral Health, 2007; 8(3):124-128.

20. Auvray L, Letourneau B, Freysz M. Mastocytosis: general anesthesia with remifentanil and sevoflurane. Ann Fr Anesth Reanim, 2001; 20:635–638.

21. Borgeat A, Ruetsch YA. Anesthesia in a patient with malignant systemic mastocytosis using a total intravenous anesthetic technique. Anesth Analg, 1998; 86:442–444.

22. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy, 2008; 63:226–232.

23. Heide R, Beishuizen A, De Groot H, et al. Mastocytosis in children: A protocol for management. Pediatr Dermatol, 2008; 25(4):493-500.

24. Kim JH, Park SH, Moon YW, et al. Histamine H1receptor induces cytosolic calcium increase and aquaporin translocation in human salivary gland cells. J Pharmacol Exp Ther, 2009; 330:403–412.

25. Jorgensen GH, Arnlaugsson S, Theodors A, Ludviksson BR. Immunoglobulin A deficiency and oral health status: a case–control study. J Clin Periodontol, 2010; 37:1–8.